- Home
- CPOP vs SER Comparison
CPOP vs SER Comparison
Compare CPOP & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CPOP | SER |
|---|---|---|
| Founded | 2007 | 2017 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.4M | 29.3M |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | CPOP | SER |
|---|---|---|
| Price | $0.36 | $1.86 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $13.00 |
| AVG Volume (30 Days) | 93.7K | ★ 3.6M |
| Earning Date | 11-17-2025 | 03-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $107,632,769.00 | $116,000.00 |
| Revenue This Year | N/A | $134.46 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 127.16 | N/A |
| 52 Week Low | $0.33 | $1.71 |
| 52 Week High | $2.61 | $7.92 |
Technical Indicators
Market Signals| Indicator | CPOP | SER |
|---|---|---|
| Relative Strength Index (RSI) | 40.84 | 33.68 |
| Support Level | $0.33 | $2.11 |
| Resistance Level | $0.46 | $3.14 |
| Average True Range (ATR) | 0.04 | 0.36 |
| MACD | -0.00 | -0.10 |
| Stochastic Oscillator | 29.75 | 3.00 |
Price Performance
Historical ComparisonAbout CPOP Pop Culture Group Co. Ltd
Pop Culture Group Co Ltd hosts entertainment events, operates hip-hop-related online programs, and provides event planning and execution services and marketing services to corporate clients. It generates revenue from Event Hosting business by providing sponsorship packages to advertisers in exchange for sponsorship fees and by selling tickets for those concerts. The company has various operations services out of which Brand Promotion earns maximum revenue, following by Event Hosting, and Event Planning and Execution.
About SER Serina Therapeutics Inc.
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.